Koyfin Home > Directory > Health Care > Aclaris Therapts > EV / EBITDA (ltm)

Aclaris Therapts EV / EBITDA (ltm) Chart (ACRS)

Aclaris Therapts annual/quarterly EV / EBITDA (ltm) from 2019 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Aclaris Therapts EV / EBITDA (ltm) for the quarter ending July 07, 2020 was 0.02 a 78.28% increase of 0.02 year over year
  • Aclaris Therapts EV / EBITDA (ltm) for the last 12 months ending July 07, 2020 was 0.02 a 78.28% increase of 0.02 year over year
  • Aclaris Therapts Annual EV / EBITDA (ltm) for 2020 was 0.02 a -52.19% decrease of -0.01 from 2019
  • Aclaris Therapts Annual EV / EBITDA (ltm) for 2020 was 0.03 a 68.58% increase of 0.02 from 2019
  • Aclaris Therapts Annual EV / EBITDA (ltm) for 2020 was 0.01 a 54.57% increase of 0.01 from 2019
Other Valuation Metrics:
  • Aclaris Therapts Market Cap for the quarter ending March 03, 2018 was $541m a -33.92% decrease of -184m year over year
  • Aclaris Therapts Price / Book for the quarter ending March 03, 2018 was 2.40 a -83.99% decrease of -2.02 year over year
  • Aclaris Therapts Enterprise Value for the quarter ending March 03, 2018 was $348m a -64.40% decrease of -224m year over year
View Chart On Koyfin

Quarterly ACRS EV / EBITDA (ltm) Data

07/20200.02
06/20200.03
06/20200.01
06/20200.00
06/20200.03
06/20200.05
06/20200.08
06/20200.07
06/20200.05
06/20200.06

Annual ACRS EV / EBITDA (ltm) Data

20200.02
20200.03
20200.01
20200.00
20200.03
20200.05
20200.08
20200.07
20200.05
20200.06